CYTOKINETICS, INCORPORATED Interest Expense
CYTOKINETICS, INCORPORATED (CYTK) reported Interest Expense of $45.58 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-02-26
- CYTOKINETICS, INCORPORATED interest expense for the quarter ending 2025-12-31 was $14.27M, a 59.70% increase year-over-year.
- CYTOKINETICS, INCORPORATED interest expense for the quarter ending 2025-09-30 was $11.35M, a 27.16% increase year-over-year.
- CYTOKINETICS, INCORPORATED interest expense for the quarter ending 2025-06-30 was $11.08M, a 12.94% decline year-over-year.
- CYTOKINETICS, INCORPORATED interest expense for the quarter ending 2025-03-31 was $8.87M, a 24.85% increase year-over-year.
- CYTOKINETICS, INCORPORATED interest expense for fiscal 2025 was $45.58M, a 20.90% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED interest expense for fiscal 2024 was $37.70M, a 33.19% increase from fiscal 2023.
- CYTOKINETICS, INCORPORATED interest expense for fiscal 2023 was $28.31M, a 45.80% increase from fiscal 2022.
- CYTOKINETICS, INCORPORATED interest expense for fiscal 2022 was $19.41M, a 18.09% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 185 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $14.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.63M derived: sum of 2 quarters · filed 2026-02-26 | $36.71M derived: sum of 3 quarters · filed 2026-02-26 | $45.58M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $11.35M 10-Q · filed 2025-11-05 | $22.44M derived: sum of 2 quarters · filed 2025-11-05 | $31.30M 10-Q · filed 2025-11-05 | $40.24M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2025-06-30 | $11.08M 10-Q · filed 2025-08-07 | $19.95M 10-Q · filed 2025-08-07 | $28.89M derived: sum of 3 quarters · filed 2026-02-26 | $37.82M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2025-03-31 | $8.87M derived: 10-K 12 month − 3 quarters · filed 2026-02-26 | $17.81M derived: sum of 2 quarters · filed 2026-02-26 | $26.73M derived: sum of 3 quarters · filed 2026-02-26 | $39.47M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.87M derived: sum of 2 quarters · filed 2026-02-26 | $30.60M derived: sum of 3 quarters · filed 2026-02-26 | $37.70M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $8.93M 10-Q · filed 2025-11-05 | $21.66M derived: sum of 2 quarters · filed 2025-11-05 | $28.76M 10-Q · filed 2025-11-05 | $35.93M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $12.73M 10-Q · filed 2025-08-07 | $19.84M 10-Q · filed 2025-08-07 | $27.00M derived: sum of 3 quarters · filed 2026-02-26 | $34.13M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $7.10M 10-Q · filed 2024-05-10 | $14.27M derived: sum of 2 quarters · filed 2026-02-26 | $21.40M derived: sum of 3 quarters · filed 2026-02-26 | $28.45M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.30M derived: sum of 2 quarters · filed 2026-02-26 | $21.34M derived: sum of 3 quarters · filed 2026-02-26 | $28.31M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $7.14M 10-Q · filed 2024-11-07 | $14.18M derived: sum of 2 quarters · filed 2024-11-07 | $21.14M 10-Q · filed 2024-11-07 | $28.20M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $7.04M 10-Q · filed 2024-08-09 | $14.01M 10-Q · filed 2024-08-09 | $21.06M derived: sum of 3 quarters · filed 2025-02-27 | $27.87M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $6.96M 10-Q · filed 2024-05-10 | $14.02M derived: sum of 2 quarters · filed 2025-02-27 | $20.82M derived: sum of 3 quarters · filed 2025-02-27 | $23.63M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.86M derived: sum of 2 quarters · filed 2025-02-27 | $16.67M derived: sum of 3 quarters · filed 2025-02-27 | $19.41M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $6.80M 10-Q · filed 2023-11-03 | $9.61M derived: sum of 2 quarters · filed 2023-11-03 | $12.36M 10-Q · filed 2023-11-03 | $16.57M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $2.81M 10-Q · filed 2023-08-03 | $5.55M 10-Q · filed 2023-08-03 | $9.77M derived: sum of 3 quarters · filed 2024-02-28 | $13.93M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $2.75M 10-Q · filed 2023-05-05 | $6.96M derived: sum of 2 quarters · filed 2024-02-28 | $11.13M derived: sum of 3 quarters · filed 2024-02-28 | $15.20M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.38M derived: sum of 2 quarters · filed 2024-02-28 | $12.45M derived: sum of 3 quarters · filed 2024-02-28 | $16.44M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $4.16M 10-Q · filed 2022-11-04 | $8.23M derived: sum of 2 quarters · filed 2022-11-04 | $12.22M 10-Q · filed 2022-11-04 | $16.24M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $4.07M 10-Q · filed 2022-08-05 | $8.06M 10-Q · filed 2022-08-05 | $12.08M derived: sum of 3 quarters · filed 2023-03-01 | $16.05M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $3.99M 10-Q · filed 2022-05-06 | $8.01M derived: sum of 2 quarters · filed 2023-03-01 | $11.98M derived: sum of 3 quarters · filed 2023-03-01 | $15.87M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $7.99M derived: sum of 2 quarters · filed 2023-03-01 | $11.89M derived: sum of 3 quarters · filed 2023-03-01 | $15.96M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $3.98M 10-Q · filed 2021-11-05 | $7.87M derived: sum of 2 quarters · filed 2021-11-05 | $11.95M 10-Q · filed 2021-11-05 | $14.68M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $3.89M 10-Q · filed 2021-08-06 | $7.97M 10-Q · filed 2021-08-06 | $10.70M derived: sum of 3 quarters · filed 2022-02-25 | $12.04M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $4.08M 10-Q · filed 2021-05-07 | $6.81M derived: sum of 2 quarters · filed 2022-02-25 | $8.15M derived: sum of 3 quarters · filed 2022-02-25 | $9.53M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2019-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.08M derived: sum of 2 quarters · filed 2022-02-25 | $5.45M derived: sum of 3 quarters · filed 2022-02-25 | $6.62M 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $1.34M 10-Q · filed 2020-11-06 | $2.72M derived: sum of 2 quarters · filed 2020-11-06 | $3.89M 10-Q · filed 2020-11-06 | $5.06M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-06-30 | $1.38M 10-Q · filed 2020-08-07 | $2.55M 10-Q · filed 2020-08-07 | $3.72M derived: sum of 3 quarters · filed 2021-02-26 | $4.58M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-03-31 | $1.17M 10-Q · filed 2020-05-08 | $2.34M derived: sum of 2 quarters · filed 2021-02-26 | $3.21M derived: sum of 3 quarters · filed 2021-02-26 | $4.10M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2018-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.04M derived: sum of 2 quarters · filed 2021-02-26 | $2.93M derived: sum of 3 quarters · filed 2021-02-26 | $3.80M 10-K · filed 2021-02-26 | ||
| 2018-09-30 | $867.00K 10-Q · filed 2019-11-01 | $1.76M derived: sum of 2 quarters · filed 2019-11-01 | $2.63M 10-Q · filed 2019-11-01 | $3.30M derived: sum of 4 quarters · filed 2019-11-01 | ||
| 2018-06-30 | $898.00K 10-Q · filed 2019-08-09 | $1.76M 10-Q · filed 2019-08-09 | $2.43M derived: sum of 3 quarters · filed 2019-08-09 | $3.24M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $863.00K 10-Q · filed 2019-05-09 | $1.53M derived: sum of 2 quarters · filed 2019-05-09 | $2.34M derived: sum of 3 quarters · filed 2019-05-09 | $3.12M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.48M derived: sum of 2 quarters · filed 2019-03-07 | $2.26M derived: sum of 3 quarters · filed 2019-03-07 | $3.02M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | $806.00K 10-Q · filed 2018-11-09 | $1.59M derived: sum of 2 quarters · filed 2018-11-09 | $2.35M 10-Q · filed 2018-11-09 | $3.05M derived: sum of 4 quarters · filed 2018-11-09 | ||
| 2017-06-30 | $782.00K 10-Q · filed 2018-08-07 | $1.54M 10-Q · filed 2018-08-07 | $2.24M derived: sum of 3 quarters · filed 2018-08-07 | $2.95M derived: sum of 4 quarters · filed 2018-08-07 | ||
| 2017-03-31 | $745.00K 10-Q · filed 2018-05-10 | $3.05M 10-Q · filed 2017-05-04 | $1.46M derived: sum of 2 quarters · filed 2018-05-10 | $2.17M derived: sum of 3 quarters · filed 2018-05-10 | $2.88M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $1.43M derived: sum of 2 quarters · filed 2018-03-05 | $2.13M derived: sum of 3 quarters · filed 2018-03-05 | $2.70M 10-K · filed 2018-03-05 | ||
| 2016-09-30 | $714.00K 10-Q · filed 2017-11-03 | $1.42M derived: sum of 2 quarters · filed 2017-11-03 | $1.99M 10-Q · filed 2017-11-03 | $2.25M derived: sum of 4 quarters · filed 2018-03-05 | ||
| 2016-06-30 | $707.00K 10-Q · filed 2017-08-04 | $1.27M 10-Q · filed 2017-08-04 | $1.54M derived: sum of 3 quarters · filed 2018-03-05 | $1.54M derived: sum of 4 quarters · filed 2018-03-05 | ||
| 2016-03-31 | $563.00K 10-Q · filed 2017-05-04 | $831.00K derived: sum of 2 quarters · filed 2018-03-05 | $831.00K derived: sum of 3 quarters · filed 2018-03-05 | |||
| 2015-12-31 | $268.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | $268.00K derived: sum of 2 quarters · filed 2018-03-05 | $268.00K 10-K · filed 2018-03-05 | |||
| 2015-09-30 | $0.00 10-Q/A · filed 2016-12-15 | $0.00 10-Q/A · filed 2016-12-15 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-06 | |||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-06 | |||||
| 2012-12-31 | $3.00K 10-K · filed 2015-03-06 | $5.38M 10-K · filed 2013-03-15 | ||||
| 2011-12-31 | $35.00K 10-K · filed 2014-03-07 | |||||
| 2010-12-31 | $176.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |